156 related articles for article (PubMed ID: 38602703)
21. Comparative costs of advanced proton and photon radiation therapies: lessons from time-driven activity-based costing in head and neck cancer.
Thaker NG; Frank SJ; Feeley TW
J Comp Eff Res; 2015 Aug; 4(4):297-301. PubMed ID: 26274791
[No Abstract] [Full Text] [Related]
22. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
[TBL] [Abstract][Full Text] [Related]
23. The financial burden of cancer: estimates from patients undergoing cancer care in a tertiary care hospital.
Zaidi AA; Ansari TZ; Khan A
Int J Equity Health; 2012 Oct; 11():60. PubMed ID: 23061477
[TBL] [Abstract][Full Text] [Related]
24. Cost and Healthcare Utilization Among Non-Elderly Head and Neck Cancer Patients in the Military Health System, a Single-Payer Universal Health Care Model.
Ambrosio A; Jeffery DD; Hopkins L; Burke HB
Mil Med; 2019 May; 184(5-6):e400-e407. PubMed ID: 30295883
[TBL] [Abstract][Full Text] [Related]
25. Assessing the Prevalence of Financial Toxicity, its Predictors and Association with Health- Related Quality of Life Among Radiation Oncology Patients in India: A Cross-Sectional Patient Reported Outcome Study.
Dar MA; Chauhan R; Trivedi V; Kumar R; Dhingra S
Int J Radiat Oncol Biol Phys; 2023 May; 116(1):157-165. PubMed ID: 36455689
[TBL] [Abstract][Full Text] [Related]
26. Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients.
Kim Le T; Winfree KB; Yang H; Marynchenko M; Yu AP; Frois C; Wu EQ
J Med Econ; 2012; 15(4):786-95. PubMed ID: 22475042
[TBL] [Abstract][Full Text] [Related]
27. Associations between neighbourhood support and financial burden with unmet needs of head and neck cancer survivors.
O'Brien KM; Timmons A; Butow P; Gooberman-Hill R; O'Sullivan E; Balfe M; Sharp L
Oral Oncol; 2017 Feb; 65():57-64. PubMed ID: 28109469
[TBL] [Abstract][Full Text] [Related]
28. A National Evaluation of Food Insecurity in a Head and Neck Cancer Population.
Berger MH; Lin HW; Bhattacharyya N
Laryngoscope; 2021 May; 131(5):E1539-E1542. PubMed ID: 33098320
[TBL] [Abstract][Full Text] [Related]
29. The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up.
van Agthoven M; van Ineveld BM; de Boer MF; Leemans CR; Knegt PP; Snow GB; Uyl-de Groot CA
Eur J Cancer; 2001 Nov; 37(17):2204-11. PubMed ID: 11677108
[TBL] [Abstract][Full Text] [Related]
30. Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer.
Lenze NR; Bensen JT; Farnan L; Sheth S; Zevallos JP; Yarbrough WG; Zanation AM
Head Neck; 2022 Feb; 44(2):412-419. PubMed ID: 34793605
[TBL] [Abstract][Full Text] [Related]
31. Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries.
Lafuma A; Cotté FE; Le Tourneau C; Emery C; Gaudin AF; Torreton E; Gourmelen J; Bonastre J
J Med Econ; 2019 Jul; 22(7):698-705. PubMed ID: 30895832
[No Abstract] [Full Text] [Related]
32. The Value of Productivity in Health Policy.
Van den Hout W
Appl Health Econ Health Policy; 2015 Aug; 13(4):311-3. PubMed ID: 25917686
[No Abstract] [Full Text] [Related]
33. Clinical economics of head and neck malignancies.
Sherman EJ; Ruchlin HS; Holden JS; Pfister DG
Hematol Oncol Clin North Am; 1999 Aug; 13(4):867-81. PubMed ID: 10494519
[TBL] [Abstract][Full Text] [Related]
34. Financial Hardship in Patients With Head and Neck Cancer.
Mott NM; Mierzwa ML; Casper KA; Shah JL; Mallen-St Clair J; Ho AS; Zumsteg ZS; Prince MEP; Dossett LA; Chen MM
JCO Oncol Pract; 2022 Jun; 18(6):e925-e937. PubMed ID: 35167324
[TBL] [Abstract][Full Text] [Related]
35. IMRT for head and neck cancer: Cost implications.
Razfar A; Mundi J; Grogan T; Lee S; Elashoff D; Abemayor E; St John M
Am J Otolaryngol; 2016; 37(6):479-483. PubMed ID: 27968955
[TBL] [Abstract][Full Text] [Related]
36. Effect of comorbidity on short-term outcomes and cost of care after head and neck cancer surgery in the elderly.
Genther DJ; Gourin CG
Head Neck; 2015 May; 37(5):685-93. PubMed ID: 24596299
[TBL] [Abstract][Full Text] [Related]
37. Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.
Beeler WH; Bellile EL; Casper KA; Jaworski E; Burger NJ; Malloy KM; Spector ME; Shuman AG; Rosko A; Stucken CL; Chinn SB; Dragovic AF; Chapman CH; Owen D; Jolly S; Bradford CR; Prince MEP; Worden FP; Jagsi R; Mierzwa ML; Swiecicki PL
Oral Oncol; 2020 Feb; 101():104521. PubMed ID: 31877502
[TBL] [Abstract][Full Text] [Related]
38. Modern methods to predict costs for the treatment and management of head and neck cancer patients: examples of methods used in the current literature.
Wineland AM; Stack BC
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):113-6. PubMed ID: 18327029
[TBL] [Abstract][Full Text] [Related]
39. Financial Toxicity in Head and Neck Cancer Patients Treated With Proton Therapy.
Smith GL; Shih YT; Frank SJ
Int J Part Ther; 2021; 8(1):366-373. PubMed ID: 34285962
[TBL] [Abstract][Full Text] [Related]
40. Global Burden of Head and Neck Cancer: Economic Consequences, Health, and the Role of Surgery.
Patterson RH; Fischman VG; Wasserman I; Siu J; Shrime MG; Fagan JJ; Koch W; Alkire BC
Otolaryngol Head Neck Surg; 2020 Mar; 162(3):296-303. PubMed ID: 31906785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
